Austco Healthcare (ASX:AHC): FY26 Results and CareTech–RTM Acquisitions

Aditi Sarkar

23 October 2026 04:27 PM AEDT

Austco Healthcare (ASX:AHC): FY26 Results and CareTech–RTM Acquisitions

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Austco Healthcare (ASX:AHC) reported FY26 revenue of AUD 94.2 million, up 16%.
FY26 EBITDA reached AUD 14.9 million and net profit after tax reached AUD 9.0 million.
October 2026 agreements cover the acquisition of RTM Solutions and CareTech Systems.
The proposed transactions include AUD 12.44 million in combined upfront consideration.

Austco Healthcare Limited supplies nurse call, mobile communication and clinical workflow technology to hospitals and aged-care facilities internationally. At the time of writing on 23 October 2026, Austco Healthcare (ASX:AHC) was quoted at AUD 0.29, up 1.75% for the trading session. Its latest developments include FY26 financial results, agreements to acquire two complementary Australian technology businesses and an October annual general meeting.

Company Business

Austco Healthcare (ASX:AHC) develops and supplies healthcare communication systems, including its Tacera and Medicom nurse call platforms, Pulse Mobile applications, real-time location services and enterprise reporting capabilities. Its systems are used to connect patients and care staff, manage alerts and support clinical workflows. The company is headquartered in Port Melbourne, with direct operations and distributors serving healthcare customers in multiple regions.

The group combines its own technology with installation, integration and maintenance services. Its customers include hospitals, aged-care operators and other care facilities. Business performance depends on project delivery schedules, the installation of new systems, equipment upgrades and ongoing support contracts. The company says its solutions are used in more than 5,000 healthcare facilities worldwide.

Recent Development

In October 2026, Austco Healthcare (ASX:AHC) signed a binding agreement to acquire RTM Hold Co Pty Ltd, whose subsidiaries provide real-time monitoring, reporting and systems-integration software for healthcare and aged care. RTM extends Austco’s capabilities beyond bedside alerts into monitoring connected systems across a facility. The proposed acquisition remains subject to completion conditions.

On the same date, the company announced an inter-conditional agreement to acquire CareTech Systems, a Brisbane-based designer of nurse call equipment for aged-care settings and smaller hospitals. CareTech products are installed at approximately 200 sites. The transaction adds wireless call points, pendants, mats and other devices alongside the company’s existing systems. Austco expects both transactions to complete around 1 December 2026, subject to conditions.

CareTech carries AUD 3.0 million in upfront cash consideration plus a performance-based earnout. Its estimated total consideration is AUD 4.04 million, but the earnout is uncapped and depends on subsequent earnings. Together, the RTM and CareTech agreements involve approximately AUD 12.44 million in upfront consideration. Austco intends to fund the payments with existing cash and a new AUD 12.0 million debt facility; no shares are planned as purchase consideration.

The October annual general meeting also included management presentations and shareholder resolutions. Earlier in August, Austco completed the acquisition of Medical Communications Systems, extending the group’s service and distribution activities. The recently announced RTM and CareTech agreements are distinct from that completed transaction.

Financial Performance and Sector Context

Austco Healthcare (ASX:AHC) reported FY26 revenue of AUD 94.2 million, an increase of 16% from FY25. EBITDA rose 14% to AUD 14.9 million, while net profit after tax grew 52% to AUD 9.0 million. These measures reflect the year ended 30 June 2026 and precede the proposed RTM and CareTech acquisitions, so the planned transactions are not included in those reported group results.

For H1 FY26, the company had recorded revenue from customers of AUD 48.2 million against AUD 36.9 million a year earlier. H1 EBITDA was AUD 8.3 million compared with AUD 5.2 million, and profit after tax was AUD 4.7 million against AUD 2.9 million. This comparison indicates that acquisitions and existing operations both contributed to activity during the financial year.

In the twelve months to June 2026, CareTech generated unaudited revenue of AUD 3.4 million and normalised EBITDA of approximately AUD 0.9 million. Of its revenue, AUD 1.5 million represented sales to RTM that would be eliminated on group consolidation if both deals complete. Austco estimates a seven-month FY27 contribution from CareTech of AUD 1.1 million in net revenue and AUD 0.5 million in EBITDA, after those eliminations.

Healthcare facilities’ technology procurement, replacement cycles and staffing needs influence demand for communication and workflow products. Sales can also depend on budget approvals, project installation timing and local equipment certification. Company targets and acquisition contribution estimates are forward-looking rather than reported FY26 earnings.

Risks to Consider

Austco Healthcare (ASX:AHC) is exposed to delays in installation projects, hospital and aged-care procurement decisions, component costs and currency movements across its international activities. The proposed acquisitions introduce completion, financing and integration risks. CareTech’s uncapped earnout could increase total cash consideration, and expected financial contributions rely on the timing and performance of the acquired businesses. Product distribution into additional jurisdictions may require certification.

What to Watch Next

Key monitoring points for Austco Healthcare (ASX:AHC) include completion of the RTM and CareTech transactions, the final acquisition costs and the integration of software and hardware offerings. Subsequent reporting will show how acquisition financing affects cash and borrowing levels. The next interim results should also provide detail on sales composition, EBITDA, the order pipeline and contributions from businesses acquired in 2026.

Key Insights

Austco’s FY26 report recorded increases in revenue, EBITDA and net profit after tax. Its October agreements would add real-time monitoring software and owned nurse call products if completed. For Austco Healthcare (ASX:AHC), the material developments to monitor are deal completion, integration expenditure, recurring service revenue, reported earnings and available funding.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.